Spotlight survey on immunogenicity
The immunogenicity of biologics is a significant concern, which can affect safety and efficacy. In this Spotlight we will explore recent developments in immunogenicity, highlight key challenges when reviewing immunogenicity, and explore current regulations.
To kick-start this special focus, we wanted to hear your thoughts on the topic – click here to complete our short survey on immunogencity and be the first to receive our informative infographic collated from the survey results.